Product correctly added to cart.

discount label
(R)-Crizotinib-d5 (piperidine-3,3,4,5,5-d5)
View 3D

TRC logo

(R)-Crizotinib-d5 (piperidine-3,3,4,5,5-d5)

CAS: 1395950-84-1

Ref. TR-C785001

5mg
1,512.00 €
10mg
2,344.00 €
Estimated delivery in United States, on Tuesday 10 Dec 2024

Product Information

Name:
(R)-Crizotinib-d5 (piperidine-3,3,4,5,5-d5)
Controlled Product
Synonyms:
  • 2-Pyridinamine
  • 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl-3,3,4,5,5-d5)-1H-pyrazol-4-yl]- (ACI)
  • 3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl-3,3,4,5,5-d5)-1H-pyrazol-4-yl]-2-pyridinamine (ACI)
Description:

Applications (R)-Crizotinib-d5 (piperidine-3,3,4,5,5-d5) (CAS# 1395950-84-1) is a useful isotopically labeled research compound.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
TRC
Long term storage:
Notes:

Chemical properties

Molecular weight:
455.3675
Formula:
C21D5H17Cl2FN5O
Color/Form:
Neat
InChI:
InChI=1S/C21H22Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27)/t12-/m1/s1/i4D2,5D2,15D
InChI key:
InChIKey=KTEIFNKAUNYNJU-LJIFSARKSA-N
SMILES:
[2H]C1([2H])CNCC([2H])([2H])C1([2H])n1cc(-c2cnc(N)c(O[C@H](C)c3c(Cl)ccc(F)c3Cl)c2)cn1
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: TR-C785001 (R)-Crizotinib-d5 (piperidine-3,3,4,5,5-d5)

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".